The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126990602 12699060 2 F 20160909 20160830 20160914 EXP US-GLAXOSMITHKLINE-US2016GSK124837 GLAXOSMITHKLINE 0.00 F Y 0.00000 20160914 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126990602 12699060 1 PS WELLBUTRIN BUPROPION HYDROCHLORIDE 1 UNK 18644 TABLET
126990602 12699060 2 SS XYREM SODIUM OXYBATE 1 2.25 G, BID U 0 2.25 G BID
126990602 12699060 3 SS XYREM SODIUM OXYBATE 1 Oral 2.5 G, BID U 0 2.5 G BID
126990602 12699060 4 SS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 0 2.25 G BID
126990602 12699060 5 SS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID U 0 2.25 G BID
126990602 12699060 6 SS XYREM SODIUM OXYBATE 1 Oral 3 G, BID U 0 3 G BID
126990602 12699060 7 C AMLODIPINE BESYLATE. AMLODIPINE BESYLATE 1 U 0
126990602 12699060 8 C ASPIRIN. ASPIRIN 1 U 0
126990602 12699060 9 C ATENOLOL. ATENOLOL 1 UNK U 0
126990602 12699060 10 C EFFIENT PRASUGREL HYDROCHLORIDE 1 UNK U 0
126990602 12699060 11 C LIPITOR ATORVASTATIN CALCIUM 1 UNK U 0
126990602 12699060 12 C NITROSTAT NITROGLYCERIN 1 UNK U 0
126990602 12699060 13 C RANEXA RANOLAZINE 1 UNK U 0
126990602 12699060 14 C FUROSEMIDE. FUROSEMIDE 1 UNK U 0
126990602 12699060 15 C SINGULAIR MONTELUKAST SODIUM 1 UNK U 0
126990602 12699060 16 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126990602 12699060 1 Product used for unknown indication
126990602 12699060 2 Narcolepsy
126990602 12699060 3 Cataplexy
126990602 12699060 7 Product used for unknown indication
126990602 12699060 8 Product used for unknown indication
126990602 12699060 9 Product used for unknown indication
126990602 12699060 10 Product used for unknown indication
126990602 12699060 11 Product used for unknown indication
126990602 12699060 12 Product used for unknown indication
126990602 12699060 13 Product used for unknown indication
126990602 12699060 14 Product used for unknown indication
126990602 12699060 15 Product used for unknown indication
126990602 12699060 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126990602 12699060 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126990602 12699060 Coronary artery disease
126990602 12699060 Drug ineffective
126990602 12699060 Feeling abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126990602 12699060 1 201608 0
126990602 12699060 2 200211 200808 0
126990602 12699060 3 200808 200908 0
126990602 12699060 4 200908 0
126990602 12699060 5 201109 201109 0
126990602 12699060 6 201109 201509 0
126990602 12699060 9 201608 0
126990602 12699060 10 201608 0
126990602 12699060 11 201608 0
126990602 12699060 12 201608 0
126990602 12699060 13 201608 0
126990602 12699060 14 20121221 201608 0
126990602 12699060 15 20121221 0
126990602 12699060 16 201312 0